Early-life skin molecular signatures are predictive of atopic dermatitis risk in an Asian preconception birth cohort

Early identification of infants at risk of atopic dermatitis (AD) is critical for timely prevention, yet preclinical biomarkers remain elusive. In this nested study within the prospective Singapore Preconception Study of Long-Term Maternal and Child Outcomes (S-PRESTO) cohort (ClinicalTrials.gov NCT03531658), we investigated whether early molecular signatures of infant skin could predict disease onset. The primary endpoint was physician-diagnosed AD by 18 months of age; secondary endpoints included AD severity and longitudinal trajectories of skin metagenomic, metabolomic, and proteomic profiles. Non-lesional skin tape strips were collected longitudinally from 119 infants (60 AD cases, 59 controls) at week 1 and months 3, 6, and 18. Here, we show that distinct microbial and host molecular alterations significantly precede clinical manifestation. Healthy infants exhibited progressive microbial diversity, transitioning from Staphylococcus epidermidis to lipophilic commensals, accompanied by butanoate fermentation and elevated natural moisturizing factors. Conversely, infants developing AD displayed early dysbiosis, driven by Pseudomonas stutzeri at week 1 and Staphylococcus aureus by month 3, alongside premature upregulation of antimicrobial peptides and uncoupled host-microbiome interactions. Predictive models showed strong performance in stratifying AD risk, shifting from microbial and peptide markers at week 1 to sustained inflammation at month 3. These preclinical signatures offer practical non-invasive tools for early infant risk stratification.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-21
DOI
https://doi.org/10.1038/s41467-026-79674-4
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early-life skin molecular signatures are predictive of atopic dermatitis risk in an Asian preconception birth cohort

YAP-SENG CHONG, Minghao Chia, Kaibo Duan, Elizabeth Huiwen Tham et al.
Nature Communications
Dermatology and Skin Diseases
article

Early-life skin molecular signatures are predictive of atopic dermatitis risk in an Asian preconception birth cohort

YAP-SENG CHONG, Minghao Chia, Kaibo Duan, Elizabeth Huiwen Tham, Jerry Kok Yen Chan, Kok Wee Chong, Evelyn Xiu Ling Loo, Zai Ru Cheng, Lynette Pei‐Chi Shek, John Common, Niranjan Nagarajan, Kok Hian Tan, Oon Hoe Teoh, Yung Seng Lee, Fabian K. P. Yap, Si Hui Goh, Le Duc Huy Ta, Seong Soo Lim, Anne Goh, Hugo P.S. Van Bever, Stephen Wearne, Bee Wah Lee
article en

Abstract

Early identification of infants at risk of atopic dermatitis (AD) is critical for timely prevention, yet preclinical biomarkers remain elusive. In this nested study within the prospective Singapore Preconception Study of Long-Term Maternal and Child Outcomes (S-PRESTO) cohort (ClinicalTrials.gov NCT03531658), we investigated whether early molecular signatures of infant skin could predict disease onset. The primary endpoint was physician-diagnosed AD by 18 months of age; secondary endpoints included AD severity and longitudinal trajectories of skin metagenomic, metabolomic, and proteomic profiles. Non-lesional skin tape strips were collected longitudinally from 119 infants (60 AD cases, 59 controls) at week 1 and months 3, 6, and 18. Here, we show that distinct microbial and host molecular alterations significantly precede clinical manifestation. Healthy infants exhibited progressive microbial diversity, transitioning from Staphylococcus epidermidis to lipophilic commensals, accompanied by butanoate fermentation and elevated natural moisturizing factors. Conversely, infants developing AD displayed early dysbiosis, driven by Pseudomonas stutzeri at week 1 and Staphylococcus aureus by month 3, alongside premature upregulation of antimicrobial peptides and uncoupled host-microbiome interactions. Predictive models showed strong performance in stratifying AD risk, shifting from microbial and peptide markers at week 1 to sustained inflammation at month 3. These preclinical signatures offer practical non-invasive tools for early infant risk stratification.

Nature Communications
Agency for Science, Technology and Research (SG), National University of Singapore (SG), SingHealth Duke-NUS Academic Medical Centre (SG), KK Women's and Children's Hospital (SG), Duke-NUS Medical School (SG), NIHR Newcastle Biomedical Research Centre (GB), Bioinformatics Institute (SG), National University Health System (SG), Genome Institute of Singapore (SG)
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon